MedPath

ong Term Change In Ocular Surface Microbes With Vectored Thermal Pulsation Treatment In Meibomian Gland Dysfunction- A Pilot Study

Not Applicable
Conditions
Health Condition 1: H118- Other specified disorders of conjunctiva
Registration Number
CTRI/2020/08/027116
Lead Sponsor
Dr R P centre for ophthalmic sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

18 years of age and above

Newly diagnosed cases with symptomatic MGD mild to moderate(Stage 2 and 3)

Meibomian gland area loss: nil to medium dropout on visual inspection of images analyzed by Lipiscan.

Lipid layer thickness less than 100nm seen on Lipiview II.

Providing written Informed Consent for Treatment

Exclusion Criteria

Patients having other ocular surface disorder e.g. steven johnson syndrome, ocular pemphigoid, chemical injury, limbal stem cell deficiency etc. (Plus disease)

Patients undergoing any current treatment for MGD/ dry eye

Patients with history of any ocular surgery in previous 3 months.

Ocular injury within prior 3 months

Ocular herpes of eye/eyelid within prior 3 months

Active ocular infection

Active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months

Eyelid abnormalities that affect lid function

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath